Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Falcon and Draeger recall laryngoscope blade lots

This article was originally published in Clinica

Executive Summary

Falcon Surgical, the Sialkot, Pakistan device manufacturer, is urgently recalling certain lots of its Miller single-use paediatric laryngoscope blades, sizes 00, 0 and 1. Sixteen lots (seven, four and five respectively) are thought to be affected by two possible manufacturing faults related to "poor focus of the beam" or "heating of the bulb", according to an August 9 notice issued by Falcon.

You may also be interested in...



Henlius Has Denosumab Application Accepted In China

Shanghai Henlius Biotech has announced that China’s NMPA has accepted the firm’s filing for its HLX14 denosumab biosimilar. Meanwhile, the company has also announced dosing the first patient in a Phase II clinical trial of its novel HLX10 anti-PD-1 monoclonal antibody.

Global AMR R&D Hub launches Dynamic Data Dashboard

The Global AMR R&D Hub’s newly launched Dynamic Dashboard aims to be “a comprehensive knowledge center for AMR R&D and market reforms,” its head tells Scrip.

AzarGen And iBio Push On With Plant-Based Rituximab

AzarGen and iBio have advanced their alliance, with the latter revealing it would now begin manufacturing and characterizing additional supplies of plant-based rituximab, to enable pre-clinical studies comparing it with Roche’s MabThera original.

Topics

UsernamePublicRestriction

Register

MT049465

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel